DrugPatentWatch Database Preview
Rubicon Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for RUBICON, and what generic and branded alternatives to RUBICON drugs are available?
RUBICON has twenty approved drugs.
Summary for Rubicon
| US Patents: | 0 |
| Tradenames: | 18 |
| Ingredients: | 18 |
| NDAs: | 20 |
Drugs and US Patents for Rubicon
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rubicon | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 090807-002 | May 2, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Rubicon | LAMOTRIGINE | lamotrigine | TABLET;ORAL | 078625-004 | Jan 27, 2009 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Rubicon | CLONAZEPAM | clonazepam | TABLET;ORAL | 075468-003 | Oct 6, 2000 | DISCN | No | No | Start Trial | Start Trial | |||||
| Rubicon | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 200981-002 | Oct 28, 2014 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Rubicon | LAMOTRIGINE | lamotrigine | TABLET;ORAL | 078625-002 | Jan 27, 2009 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Rubicon | GABAPENTIN | gabapentin | TABLET;ORAL | 077661-005 | Sep 13, 2006 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Rubicon | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 090807-001 | May 2, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
